{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:48:11Z","timestamp":1789382891341,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mesenchymal stem cell (MSCs) transplantation has been used to treat Sj\u00f6gren\u2019s syndrome (SS) based on the immunoregulatory properties of MSCs. However, the effectiveness need improving and its underlying intrinsic mechanisms remain largely unknown. Here, we show that <jats:italic>Id3<\/jats:italic> is upregulated in bone marrow-derived MSCs (BMMSCs) isolated from NOD\/ShiLtJ mice, a widely used SS model, compared with ICR mice as control, suggesting that it functions in SS development and therapy. Transplantation of <jats:italic>Id3<\/jats:italic>-deficient BMMSCs rescues salivary gland function more effective than wild-type BMMSCs in NOD\/ShiLtJ mice. Mechanistically, we show that ID3 negatively regulated BMP4 expression by preventing binding of basic helix\u2013loop\u2013helix protein E2A to the promoter of the <jats:italic>Bmp4<\/jats:italic> gene. BMP4 in turn promoted PGE2 production in MSCs, and exhibited enhanced suppressive activities of T-cell proliferation and Th1 differentiation. Importantly, BMMSCs from SS patients showed significantly lower BMP4 and PGE2 expression than those from healthy individuals. Taken together, our findings revealed the targeting Id3 may be therapeutically useful for improving MSC immunoregulation and effectiveness of MSCs therapy for SS.<\/jats:p>","DOI":"10.1038\/s41419-020-2359-6","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T17:03:07Z","timestamp":1583427787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Depletion of ID3 enhances mesenchymal stem cells therapy by targeting BMP4 in Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1038","volume":"11","author":[{"given":"Lei","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaozhong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"key":"2359_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","volume":"366","author":"RI Fox","year":"2005","unstructured":"Fox, R. I. Sjogren\u2019s syndrome. Lancet 366, 321 (2005).","journal-title":"Lancet"},{"key":"2359_CR2","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","volume":"120","author":"J Xu","year":"2012","unstructured":"Xu, J. et al. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome. Blood 120, 3142 (2012).","journal-title":"Blood"},{"key":"2359_CR3","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1186\/ar4520","volume":"16","author":"D Wang","year":"2014","unstructured":"Wang, D. et al. Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study. Arthritis Res. Ther. 16, R79 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"2359_CR4","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/art.27548","volume":"62","author":"L Sun","year":"2010","unstructured":"Sun, L. et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum. 62, 2467 (2010).","journal-title":"Arthritis Rheum."},{"key":"2359_CR5","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","volume":"388","author":"J Panes","year":"2016","unstructured":"Panes, J. et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial. Lancet 388, 1281 (2016).","journal-title":"Lancet"},{"key":"2359_CR6","volume":"13","author":"O Fernandez","year":"2018","unstructured":"Fernandez, O. et al. Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I\/II safety and feasibility study. PLoS ONE 13, e195891 (2018).","journal-title":"PLoS ONE"},{"key":"2359_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ebiom.2018.02.002","volume":"29","author":"VK Harris","year":"2018","unstructured":"Harris, V. K. et al. Phase I trial of intrathecal mesenchymal stem cell-derived neural progenitors in progressive multiple sclerosis. EBioMedicine 29, 23 (2018).","journal-title":"EBioMedicine"},{"key":"2359_CR8","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1136\/annrheumdis-2017-211073","volume":"76","author":"D Deng","year":"2017","unstructured":"Deng, D., Zhang, P., Guo, Y. & Lim, T. O. A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis. Ann. Rheum. Dis. 76, 1436 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"2359_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/B978-0-12-405943-6.00005-1","volume":"110","author":"F Ling","year":"2014","unstructured":"Ling, F., Kang, B. & Sun, X. H. Id proteins: small molecules, mighty regulators. Curr. Top Dev. Biol. 110, 189 (2014).","journal-title":"Curr. Top Dev. Biol."},{"key":"2359_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.devcel.2015.10.019","volume":"35","author":"LH Wang","year":"2015","unstructured":"Wang, L. H. & Baker, N. E. E proteins and ID proteins: helix-loop-helix partners in development and disease. Dev. Cell 35, 269 (2015).","journal-title":"Dev. C"},{"key":"2359_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrc3638","volume":"14","author":"A Lasorella","year":"2014","unstructured":"Lasorella, A., Benezra, R. & Iavarone, A. The ID proteins: master regulators of cancer stem cells and tumour aggressiveness. Nat. Rev. Cancer 14, 77 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"2359_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.devcel.2015.10.019","volume":"35","author":"LH Wang","year":"2015","unstructured":"Wang, L. H. & Baker, N. E. E Proteins and ID Proteins: Helix-Loop-Helix Partners in Development and Disease. Dev Cell 35, 269 (2015).","journal-title":"Dev Cell"},{"key":"2359_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.stem.2018.06.001","volume":"23","author":"SK Singh","year":"2018","unstructured":"Singh, S. K. et al. Id1 ablation protects hematopoietic stem cells from stress-induced exhaustion and aging. Cell Stem Cell 23, 252 (2018).","journal-title":"Cell Stem Cell"},{"key":"2359_CR14","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/ncb2490","volume":"14","author":"F Niola","year":"2012","unstructured":"Niola, F. et al. Id proteins synchronize stemness and anchorage to the niche of neural stem cells. Nat. Cell Biol. 14, 477 (2012).","journal-title":"Nat. Cell Biol."},{"key":"2359_CR15","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/ni1260","volume":"6","author":"C Murre","year":"2005","unstructured":"Murre, C. Helix-loop-helix proteins and lymphocyte development. Nat. Immunol. 6, 1079 (2005).","journal-title":"Nat. Immunol."},{"key":"2359_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S1074-7613(00)80155-7","volume":"12","author":"RR Rivera","year":"2000","unstructured":"Rivera, R. R., Johns, C. P., Quan, J., Johnson, R. S. & Murre, C. Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3. Immunity 12, 17 (2000).","journal-title":"Immunity"},{"key":"2359_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/ni.1965","volume":"12","author":"T Maruyama","year":"2011","unstructured":"Maruyama, T. et al. Control of the differentiation of regulatory T cells and T(H)17 cells by the DNA-binding inhibitor Id3. Nat. Immunol. 12, 86 (2011).","journal-title":"Nat. Immunol."},{"key":"2359_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/85303","volume":"2","author":"BL Kee","year":"2001","unstructured":"Kee, B. L., Rivera, R. R. & Murre, C. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-beta. Nat. Immunol. 2, 242 (2001).","journal-title":"Nat. Immunol."},{"key":"2359_CR19","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/ni.3252","volume":"16","author":"H Nakatsukasa","year":"2015","unstructured":"Nakatsukasa, H. et al. The DNA-binding inhibitor Id3 regulates IL-9 production in CD4(+) T cells. Nat. Immunol. 16, 1077 (2015).","journal-title":"Nat. Immunol."},{"key":"2359_CR20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.immuni.2004.08.013","volume":"21","author":"H Li","year":"2004","unstructured":"Li, H., Dai, M. & Zhuang, Y. A T cell intrinsic role of Id3 in a mouse model for primary Sjogren\u2019s syndrome. Immunity 21, 551 (2004).","journal-title":"Immunity"},{"key":"2359_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.imlet.2010.09.009","volume":"135","author":"Z Guo","year":"2011","unstructured":"Guo, Z. et al. Modeling Sjogren\u2019s syndrome with Id3 conditional knockout mice. Immunol. Lett. 135, 34 (2011).","journal-title":"Immunol. Lett."},{"key":"2359_CR22","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.2174\/1381612821666150316120024","volume":"21","author":"YS Park","year":"2015","unstructured":"Park, Y. S., Gauna, A. E. & Cha, S. Mouse models of primary Sjogren\u2019s syndrome. Curr. Pharm. Des. 21, 2350 (2015).","journal-title":"Curr. Pharm. Des."},{"key":"2359_CR23","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1182\/blood-2011-05-356063","volume":"118","author":"YX Zhu","year":"2011","unstructured":"Zhu, Y. X. et al. Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide. Blood 118, 4771 (2011).","journal-title":"Blood"},{"key":"2359_CR24","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/0092-8674(89)90434-0","volume":"58","author":"C Murre","year":"1989","unstructured":"Murre, C. et al. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58, 537 (1989).","journal-title":"Cell"},{"key":"2359_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1471-213X-9-51","volume":"9","author":"ME Jones","year":"2009","unstructured":"Jones, M. E., Kondo, M. & Zhuang, Y. A tamoxifen inducible knock-in allele for investigation of E2A function. BMC Dev. Biol. 9, 51 (2009).","journal-title":"BMC Dev. Biol."},{"key":"2359_CR26","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.jaci.2013.03.015","volume":"131","author":"K Hirahara","year":"2013","unstructured":"Hirahara, K. et al. Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease. J. Allergy Clin. Immunol. 131, 1276 (2013).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2359_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/cyto.a.22348","volume":"85","author":"L Cosmi","year":"2014","unstructured":"Cosmi, L., Maggi, L., Santarlasci, V., Liotta, F. & Annunziato, F. T helper cells plasticity in inflammation. Cytom. A 85, 36 (2014).","journal-title":"Cytom. A"},{"key":"2359_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1084\/jem.20051725","volume":"203","author":"MN Sharif","year":"2006","unstructured":"Sharif, M. N. et al. Twist mediates suppression of inflammation by type I IFNs and Axl. J. Exp. Med 203, 8 (2006).","journal-title":"J. Exp. Med"},{"key":"2359_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1084\/jem.20072468","volume":"205","author":"U Niesner","year":"2008","unstructured":"Niesner, U. et al. Autoregulation of Th1-mediated inflammation by twist1. J. Exp. Med. 205, 8 (2008).","journal-title":"J. Exp. Med."},{"key":"2359_CR30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ebiom.2015.12.020","volume":"4","author":"SV Boregowda","year":"2015","unstructured":"Boregowda, S. V. et al. Indications Prediction Scale Based on TWIST1 for Human Mesenchymal Stem Cells. EBioMedicine 4, 62 (2015).","journal-title":"EBioMedicine"},{"key":"2359_CR31","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3727\/096368910X508762","volume":"19","author":"H Yagi","year":"2010","unstructured":"Yagi, H. et al. Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant. 19, 667 (2010).","journal-title":"Cell Transplant."},{"key":"2359_CR32","doi-asserted-by":"publisher","first-page":"19838","DOI":"10.1074\/jbc.274.28.19838","volume":"274","author":"A Hollnagel","year":"1999","unstructured":"Hollnagel, A., Oehlmann, V., Heymer, J., Ruther, U. & Nordheim, A. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J. Biol. Chem. 274, 19838 (1999).","journal-title":"J. Biol. Chem."},{"key":"2359_CR33","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nri.2016.112","volume":"16","author":"W Chen","year":"2016","unstructured":"Chen, W. & Ten, D. P. Immunoregulation by members of the TGFbeta superfamily. Nat. Rev. Immunol. 16, 723 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"2359_CR34","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1182\/blood-2011-07-370650","volume":"119","author":"L Hidalgo","year":"2012","unstructured":"Hidalgo, L. et al. Expression of BMPRIA on human thymic NK cell precursors: role of BMP signaling in intrathymic NK cell development. Blood 119, 1861 (2012).","journal-title":"Blood"},{"key":"2359_CR35","doi-asserted-by":"publisher","first-page":"R58","DOI":"10.1186\/ar1923","volume":"8","author":"CP Bramlage","year":"2006","unstructured":"Bramlage, C. P. et al. Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Res. Ther. 8, R58 (2006).","journal-title":"Arthritis Res. Ther."},{"key":"2359_CR36","doi-asserted-by":"publisher","first-page":"826182","DOI":"10.1155\/2012\/826182","volume":"2012","author":"Y Tang","year":"2012","unstructured":"Tang, Y. et al. Gene expression profile reveals abnormalities of multiple signaling pathways in mesenchymal stem cell derived from patients with systemic lupus erythematosus. Clin. Dev. Immunol. 2012, 826182 (2012).","journal-title":"Clin. Dev. Immunol."},{"key":"2359_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4049\/jimmunol.1101029","volume":"188","author":"P Kalinski","year":"2012","unstructured":"Kalinski, P. Regulation of immune responses by prostaglandin E2. J. Immunol. 188, 21 (2012).","journal-title":"J. Immunol."},{"key":"2359_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1254\/jphs.09R03CP","volume":"112","author":"D Sakata","year":"2010","unstructured":"Sakata, D., Yao, C. & Narumiya, S. Prostaglandin E2, an immunoactivator. J. Pharmacol. Sci. 112, 1 (2010).","journal-title":"J. Pharmacol. Sci."},{"key":"2359_CR39","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/ng.401","volume":"41","author":"PL De Jager","year":"2009","unstructured":"De Jager, P. L. et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet. 41, 776 (2009).","journal-title":"Nat. Genet."},{"key":"2359_CR40","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature10251","volume":"476","author":"S Sawcer","year":"2011","unstructured":"Sawcer, S. et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476, 214 (2011).","journal-title":"Nature"},{"key":"2359_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.0030058","volume":"3","author":"C Libioulle","year":"2007","unstructured":"Libioulle, C. et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 3, e58 (2007).","journal-title":"PLoS Genet."},{"key":"2359_CR42","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/ng.549","volume":"42","author":"DP McGovern","year":"2010","unstructured":"McGovern, D. P. et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat. Genet. 42, 332 (2010).","journal-title":"Nat. Genet."},{"key":"2359_CR43","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/icb.2011.75","volume":"90","author":"V Sreeramkumar","year":"2012","unstructured":"Sreeramkumar, V., Fresno, M. & Cuesta, N. Prostaglandin E2 and T cells: friends or foes? Immunol. Cell Biol. 90, 579 (2012).","journal-title":"Immunol. Cell Biol."},{"key":"2359_CR44","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S1471-4906(01)02154-8","volume":"23","author":"SG Harris","year":"2002","unstructured":"Harris, S. G., Padilla, J., Koumas, L., Ray, D. & Phipps, R. P. Prostaglandins as modulators of immunity. Trends Immunol. 23, 144 (2002).","journal-title":"Trends Immunol."},{"key":"2359_CR45","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1002\/stem.512","volume":"28","author":"G Ding","year":"2010","unstructured":"Ding, G. et al. Allogeneic periodontal ligament stem cell therapy for periodontitis in swine. Stem Cells 28, 1829 (2010).","journal-title":"Stem Cells"},{"key":"2359_CR46","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/rheumatology\/ken013","volume":"47","author":"J Sellam","year":"2008","unstructured":"Sellam, J. et al. Is Inhibitor of differentiation 3 involved in human primary Sjogren\u2019s syndrome? Rheumatol. 47, 437 (2008).","journal-title":"Rheumatol."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2359-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2359-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2359-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:49:00Z","timestamp":1670251740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2359-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["2359"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2359-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,5]]},"assertion":[{"value":"3 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"172"}}